INDIGO – InterGlobe Aviation – Q4 FY26 Earnings Call – 29-May-26

INDIGO/ InterGlobe Aviation’s topline growth hinges on Middle East recovery and PRASK resilience; bottomline and margins depend on FX hedging execution, fuel cost pass-through, and utilization normalization.

1–2 minutes

Also see: INDIGO – InterGlobe Aviation – Q4 FY26 Financial Results – 29-May-26


3-Scenario Framework

📊 Base Case (50% Probability)

Middle East capacity fully restored by end-June 2026, mid-teens PRASK growth in Q1FY27 sustained by fuel surcharges, and FX hedging scales to USD 3B. CASK ex-fuel ex-FX grows mid-single digits due to utilization recovery and cost discipline. Net loss narrows as exceptional items fade, but FX and fuel headwinds persist.

Continue reading “INDIGO – InterGlobe Aviation – Q4 FY26 Earnings Call – 29-May-26”

ASIANPAINT – Asian Paints – Q4 FY26 Earnings Call – 29-May-26

ASIANPAINT/ Asian Paints’ topline resilience hinges on rural/urban demand balance and B2B growth; bottomline depends on margin defense via pricing power and backward integration; margins face structural support (premiumization, cost efficiencies) but cyclical pressure (input costs, geopolitics).

1–2 minutes

Also see: ASIANPAINT – Asian Paints – Q4 FY26 Financial Results – 29-May-26


3-Scenario Framework

📊 Base Case (60% Probability)

  • Key Variables: Commodity inflation stabilizes at current levels; geopolitical risks remain contained; rural demand sustains.
  • Outcome: 8–10% volume growth, 18–20% PBDIT margins, double-digit PAT growth. Backward integration partially offsets input costs; price hikes stick.
Continue reading “ASIANPAINT – Asian Paints – Q4 FY26 Earnings Call – 29-May-26”

INDIGO – InterGlobe Aviation – Q4 FY26 Financial Results – 29-May-26

IndiGo’s FY26 core airline remains cash‑generative (OCF ~₹234.7Bn) with ₹497Bn liquidity, but ₹89.8Bn forex losses and no hedging framework cloud earnings. Escalating lease liabilities and equity erosion add risk. Re‑rating requires credible forex hedging disclosure and two quarters of EBITDAR margin stabilisation >28%.

1–2 minutes


🔍 Observations

Topline

  • FY26 revenue from operations grew 5.1% YoY (₹808,029M → ₹849,619M), modest given fleet expansion underway; Q4FY26 revenue of ₹224,384M was flat QoQ and up just 1.3% YoY.
  • Other income surged 38.1% YoY (₹32,953M → ₹45,515M), partly cushioning operating weakness; stripping this, core operating revenue growth is thin.
  • Q4FY26 sequential revenue dip of ₹10,335M despite being a peak travel quarter signals yield pressure or capacity underutilisation.

Bottomline

  • FY26 net loss of ₹23,936M vs. net profit of ₹72,584M in FY25 — a ₹96,520M swing — driven primarily by forex loss of ₹89,757M (vs. ₹16,179M in FY25).
  • Exceptional items of ₹17,964M in FY26 (nil in FY25) added further drag; pre-exceptional, pre-forex EBIT is materially better but still compressed.
  • Q4FY26 net loss of ₹25,369M vs. Q4FY25 profit of ₹30,675M — forex loss of ₹48,229M in a single quarter is the single largest P&L distortion.

Margins

  • FY26 EBITDAR (pre-D&A, pre-finance costs, pre-rentals): Revenue ₹849,619M less fuel ₹253,892M, employee ₹82,722M, airport fees ₹65,482M, MRO ₹129,121M, other ₹83,015M, in-flight ₹4,949M = EBITDAR ~₹230,438M, margin ~27.1% vs. ~29.0% in FY25 (computed from same line items) — ~190bps compression.
  • Finance costs up 15.9% YoY (₹50,800M → ₹58,908M) and D&A up 24.5% (₹86,802M → ₹108,082M) reflect fleet-linked liability growth eating into margins.
  • Aircraft and engine rentals fell sharply (₹30,103M → ₹20,847M, -30.7%), partly offset by higher supplementary rentals and MRO (+15.1%).

Growth Trajectory

  • Revenue CAGR implied from FY25→FY26 is ~5%, well below fleet capacity addition pace — unit revenue (RASK) under pressure.
  • Total expenses grew 17.2% YoY vs. revenue growth of 5.1%, producing negative operating leverage; cost-to-income ratio deteriorated sharply.
  • Forex volatility is structural for an airline with USD-denominated lease and MRO obligations; without hedging clarity, earnings predictability remains low.
Continue reading “INDIGO – InterGlobe Aviation – Q4 FY26 Financial Results – 29-May-26”

ASIANPAINT – Asian Paints – Q4 FY26 Financial Results – 29-May-26

Asian Paints’ FY26 delivered margin recovery and record FCF despite just 5% topline growth. Q4 re‑acceleration is positive, but re‑rating hinges on H1FY27 volume growth >8–10% as Birla Opus disruption stabilises. Home décor losses narrowing and international profitability doubling are tailwinds; monitor Q1 volumes and receivables.

1–2 minutes


🔍 Observations

Topline

  • Revenue from operations grew 5.0% YoY (₹33,906 Cr → ₹35,584 Cr FY26); Q4 alone surged 10.6% YoY, signalling Q4 acceleration after a sluggish first half.
  • Decorative paints India (~84% of consolidated revenue) remains the primary driver; international business (+8.9% YoY to ₹3,340 Cr) added meaningful incremental contribution.
  • Other income jumped 26.4% YoY (₹573 Cr → ₹724 Cr), partly cushioning operating pressure — a non-trivial ₹724 Cr on a ₹35,584 Cr revenue base.

Bottomline

  • Reported PAT rose 18.4% YoY (₹3,710 Cr → ₹4,395 Cr FY26); Q4 PAT up 69.3% YoY (₹701 Cr → ₹1,185 Cr), aided by the base effect of ₹183 Cr exceptional items in Q4FY25.
  • Exceptional items (₹158 Cr in FY26 vs. ₹365 Cr in FY25) largely impairments on international/home décor subsidiaries — lower drag this year inflates apparent YoY PAT improvement.
  • Effective tax rate held steady at ~26.8% (FY26: ₹1,609 Cr on PBT ₹6,003 Cr vs. ~27.3% in FY25).

Margins

  • PBDIT margin expanded ~110 bps YoY (17.8% → 18.9% on net sales); raw material cost ratio improved — materials consumed fell from ₹15,794 Cr to ₹15,384 Cr despite ~5% revenue growth, implying meaningful gross margin recovery.
  • Net profit margin (PAT/Revenue from ops): 12.4% FY26 vs. 10.9% FY25 — a clean 150 bps expansion, driven by operating leverage and lower input costs.
  • Employee costs (+7.8% YoY) and other expenses (+5.2% YoY) grew broadly in line with revenue — cost discipline holding.

Growth Trajectory

  • FY26 topline growth (5.0%) is the slowest in several years — volume-led growth story partially stalled amid competitive intensity from Birla Opus and muted urban demand.
  • Q4 re-acceleration (+10.6% revenue, +24.4% PBDIT) is encouraging but must sustain through H1FY27 to confirm a structural recovery rather than base-effect rebound.
  • Home décor (Kitchen + Bath) remains loss-making at PBIT level (combined ~₹19 Cr loss in FY26 vs. ~₹51 Cr in FY25) — improvement trajectory present but dilutive to consolidated ROCE.
Continue reading “ASIANPAINT – Asian Paints – Q4 FY26 Financial Results – 29-May-26”

MAXHEALTH – Max Healthcare Institute – Q4 FY26 Earnings Call – 22-May-26

Max Healthcare’s topline growth hinges on non-onco scaling and greenfield execution, while margins face structural pressure from oncology mix shifts and ALOS volatility.

1–2 minutes

Also see: MAXHEALTH – Max Healthcare Institute – Q4 FY26 Financial Results – 21-May-26


3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: Oncology share stabilizes at 21–22% + Gurgaon breakeven in FY28.
Revenue grows 12–15% CAGR (ex-oncology: 15–18%) as digital/international offset oncology drag. EBITDA margins hover at 26–27% due to ALOS/labor cost lags. Free cash flow ~₹1,500 crore/year funds ₹1,200–1,500 crore annual capex, keeping net debt-to-EBITDA <1.2x.

Continue reading “MAXHEALTH – Max Healthcare Institute – Q4 FY26 Earnings Call – 22-May-26”

SUNPHARMA – Sun Pharmaceutical Industries – Q4 FY26 Earnings Call – 22-May-26

Sun Pharmaceutical Industries’ topline growth hinges on Innovative Medicines and Organon synergies, while margins and EPS are sensitive to cost normalization, tax rates, and execution risks.

1–2 minutes

Also see: SUNPHARMA – Sun Pharmaceutical Industries – Q4 FY26 Financial Results – 22-May-26


3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: Organon integration on track (Q4 FY27), Innovative Medicines growth (15–20% YoY), margin stabilization (27–28% EBITDA).
Outcome: High single-digit topline growth achieved, EPS stable with tax rate at 25%, generics recovery lagging but offset by Innovative Medicines. Semaglutide gains traction in H2 FY27.

Continue reading “SUNPHARMA – Sun Pharmaceutical Industries – Q4 FY26 Earnings Call – 22-May-26”

EICHERMOT – Eicher Motors – Q4 FY26 Earnings Call – 22-May-26

EICHERMOT/ Eicher Motors’ topline growth is structurally robust (premiumization + exports + EV), but margins hinge on commodity mitigation and capacity execution; financing JV adds long-term optionality.

1–2 minutes

Also see: EICHERMOT – Eicher Motors – Q4 FY26 Financial Results – 22-May-26


3-Scenario Framework

📊 Base Case (60% Probability)

Key Variables: Commodity inflation stabilizes at 3–3.5%, premium motorcycle demand grows 15–20%, and Cheyyar expansion delivers 2M capacity by Q2 FY28.
Outlook: Revenue grows 12–15% CAGR (driven by Royal Enfield + VECV), margins stable at ~25% (price hikes + cost reductions offset inflation), and EV/Flying Flea contributes 5–10% to revenue by FY29. Financing JV scales to INR 5K–7K crores AUM by FY28.

Continue reading “EICHERMOT – Eicher Motors – Q4 FY26 Earnings Call – 22-May-26”

HINDALCO – Hindalco Industries – Q4 FY26 Earnings Call – 22-May-26

HINDALCO’s topline leveraged to aluminum/copper prices and premiums; bottomline sensitive to exceptional items (Oswego, TC/RCs) and cost inflation; margins hinge on operational efficiencies (Novelis cost cuts, captive coal) and regional premiums.

1–2 minutes

Also see: HINDALCO – Hindalco Industries – Q4 FY26 Financial Results – 22-May-26


3-Scenario Framework

📊 Base Case (50% Probability)

Aluminum market rebalances in H2 CY26 as European/West Asia restarts and Indonesia ramp-ups offset disruptions. LME averages $2,800–3,000/ton, Midwest premiums normalize to $300–350/ton, and sulfuric acid prices correct in H2 FY27. Bay Minette ramp-up proceeds as planned, captive coal contributes modestly in FY28, and cost inflation stabilizes at ~3–5%. Consolidated EBITDA grows 8–10% in FY27, with net debt-to-EBITDA ~1.9x.

Continue reading “HINDALCO – Hindalco Industries – Q4 FY26 Earnings Call – 22-May-26”

GRASIM – Grasim Industries – Q4 FY26 Earnings Call – 20-May-26

GRASIM’s topline growth hinges on paints/B2B scale-up and macro stability; bottomline/margins depend on raw material cost pass-through and operating leverage in new businesses.

1–2 minutes

Also see: GRASIM – Grasim Industries – Q4 FY26 Financial Results – 20-May-26


3-Scenario Framework

📊 Base Case (50% Probability)

Global raw material prices stabilize by H2 FY27; price hikes stick (2–6% + Q1 FY27 increases). Paints market share gains continue (90bps+ QoQ), throughput improves with dealer maturation. B2B e-commerce hits EBITDA break-even by FY27 end. Revenue: INR 1,90,000–2,00,000 crore (FY27), EBITDA margins expand via scale and cost levers.

Continue reading “GRASIM – Grasim Industries – Q4 FY26 Earnings Call – 20-May-26”

POWERGRID – Power Grid Corporation – Q4 FY26 Earnings Call – 18-May-26

Power Grid Corporation’s topline growth is structurally robust (₹15 lakh crore+ opportunity), but bottomline and margins hinge on execution pace (CapEx → capitalization conversion) and cost mitigation (RoW, supply chain, IRR protection).

1–2 minutes

Also see: POWERGRID – Power Grid Corporation – Q4 FY26 Financial Results – 15-May-26


3-Scenario Framework

📊 Base Case (60% Probability)

CapEx sustains at ₹40,000–45,000 crore/year (FY27–FY29) with ₹30,000–35,000 crore capitalization, driven by TBCB pipeline execution (₹1.1 lakh crore bidding) and HVDC rollouts (2–3/year). RoW and supply chain bottlenecks ease via market rate mechanisms and OEM expansions. PAT grows 8–10% CAGR (FY26–FY29) on capitalization tailwinds; margins stable (~25% EBITDA) as cost inflation offset by change-in-law claims. ESG leadership and global PPPs add 5–10% to valuation premium.

Continue reading “POWERGRID – Power Grid Corporation – Q4 FY26 Earnings Call – 18-May-26”